Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Progenics PharmaceuticalsCalithera BiosciencesDynavax TechnologiesAthersysFlexion Therapeutics
SymbolNASDAQ:PGNXNASDAQ:CALANASDAQ:DVAXNASDAQ:ATHXNASDAQ:FLXN
Price Information
Current Price$4.52$5.31$6.09$2.78$12.30
52 Week RangeBuyBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.41.82.11.42.4
Analysis Score3.54.53.53.54.6
Community Score2.62.82.52.73.0
Dividend Score0.00.00.00.00.0
Ownership Score1.01.04.00.04.0
Earnings & Valuation Score0.00.60.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$12.00$8.50$16.00$10.33$23.33
% Upside from Price Target165.78% upside60.08% upside162.73% upside271.70% upside89.70% upside
Trade Information
Market Cap$386.22 million$368.42 million$597.35 million$556.02 million$458.13 million
Beta1.892.31.15-1.662.05
Average Volume566,392927,67510,113,6463,538,2091,313,870
Sales & Book Value
Annual Revenue$34.99 million$22.25 million$35.22 million$5.63 million$72.96 million
Price / Sales11.1716.8115.9497.026.50
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.54 per share$2.24 per share$0.10 per share$0.15 per share($0.53) per share
Price / Book8.362.3760.9018.53-23.21
Profitability
Net Income$-68,550,000.00$-89,860,000.00$-152,600,000.00$-44,580,000.00$-149,770,000.00
EPS($0.80)($1.90)($1.87)($0.29)($3.93)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-180.28%N/A-310.97%N/A-175.76%
Return on Equity (ROE)-129.46%-68.38%-722.75%-184.41%-592.50%
Return on Assets (ROA)-53.23%-57.43%-45.63%-104.23%-64.53%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.99%0.05%18.31%N/A27.76%
Current Ratio2.12%8.75%6.63%2.36%5.08%
Quick Ratio2.12%8.75%4.99%2.36%4.52%
Ownership Information
Institutional Ownership Percentage70.96%71.34%67.05%17.29%83.08%
Insider Ownership Percentage4.26%17.20%13.33%15.31%16.01%
Miscellaneous
Employees799023175288
Shares Outstanding86.60 million70.44 million92.18 million196.48 million38.56 million
Next Earnings Date8/14/2020 (Estimated)8/13/2020 (Estimated)8/5/2020 (Estimated)8/5/2020 (Estimated)8/4/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.